The treatment staved off cancer for seven of eight patients with a condition where the odds are rarely that good.

Add Yahoo as a preferred source to see more of our stories on Google. Researchers are finally making some progress in the ...

Results from two early-stage trials offer new hope for a cancer that kills around one in eight patients within five years.

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly ...

In separate small clinical trials, two treatments showed promise that they could help patients with one of the most dire ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

New research finds a new strategy for treating a deadly cancer by combining existing drugs to indirectly weaken tumor growth, ...

A new pill could be the future of treatment late-stage pancreatic cancer in the U.S., nearly doubling the length patients ...

A new drug extended life by nearly half a year in a clinical trial.

New data from Phase 2a clinical trial evaluating atebimetinib + mGnP in first-line pancreatic cancer will be presented in an oral session by ...

This week on "The Readout LOUD," a pancreatic cancer breakthrough and new hope for an off-the-shelf CAR-T treatment in ...

Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that new long-term clinical ...